You are here: Home » Current Affairs » Coronavirus » News
Business Standard

Donald Trump doing well, undergoing Remdesivir therapy: White House doctor

The Trump administration had issued an emergency use authorisation for Remdesivir earlier this year after the drug showed moderate effectiveness

Topics
Donald Trump | Coronavirus Tests | US Presidential elections 2020

Press Trust of India  |  Washington 

Donald Trump
White House physician Sean Conley said medical specialists have recommended Remdesivir therapy to treat the president's COVID-19 infection.

US President Donald Trump, who was shifted to a military hospital after being tested positive for COVID-19, is undergoing Remdesivir therapy and is "doing well", the White House physician has said.

The Trump administration had issued an emergency use authorisation for Remdesivir earlier this year after the drug showed moderate effectiveness in improving outcomes for patients who were hospitalised with the coronavirus.

Trump, 74, was flown to Walter Reed Military Medical Centre in Bethesda, a Maryland suburb of Washington DC, on Friday.

White House physician Sean Conley said medical specialists have recommended Remdesivir therapy to treat the president's COVID-19 infection.

"This evening, I am happy to report that the President is doing well, Conley said in a health bulletin on Friday night, the first after the president was moved to the military hospital as a precautionary measure.

He is not requiring any supplemental oxygen, but in consultation with specialists we have elected to initiate Remdesivir therapy. He has completed his first dose and is resting comfortably, he said.

Conley, in a White House memorandum, said he recommended Trump be moved to Walter Reed Military Medical Centre for further monitoring.

Trump and First Lady Melania Trump, 50, were tested positive for COVID-19 on Friday. While the president was taken to the military hospital, the First Lady stayed back at the White House.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Sat, October 03 2020. 12:05 IST
RECOMMENDED FOR YOU